Article Type
Changed
Tue, 10/03/2023 - 14:55
Display Headline
Data Trends 2023: Alzheimer’s and Dementia
References

6. Zhu CW, Sano M. Front Psychiatry. 2021;12:610334. doi:10.3389/fpsyt.2021.610334
7. Nianogo RA et al. JAMA Neurol. 2022;79(6):584-591. doi:10.1001/jamaneurol.2022.0976
8. Logue MW et al. Alzheimers Dement. 2022 Dec 22. Online ahead of print. doi:10.1002/alz.12870
9. Kempuraj D et al. Clin Ther. 2020;42(6):974-982. doi:10.1016/j.clinthera.2020.02.018
10. Martinez S et al. JAMA Neurol. 2021;78(4):473-477. doi:10.1001/jamaneurol.2020.5011
11. Verger A et al. Eur J Nucl Med Mol Imaging. 2023;50(6):1553-1555. doi:10.1007/s00259-023-06177-5

Publications
Topics
References

6. Zhu CW, Sano M. Front Psychiatry. 2021;12:610334. doi:10.3389/fpsyt.2021.610334
7. Nianogo RA et al. JAMA Neurol. 2022;79(6):584-591. doi:10.1001/jamaneurol.2022.0976
8. Logue MW et al. Alzheimers Dement. 2022 Dec 22. Online ahead of print. doi:10.1002/alz.12870
9. Kempuraj D et al. Clin Ther. 2020;42(6):974-982. doi:10.1016/j.clinthera.2020.02.018
10. Martinez S et al. JAMA Neurol. 2021;78(4):473-477. doi:10.1001/jamaneurol.2020.5011
11. Verger A et al. Eur J Nucl Med Mol Imaging. 2023;50(6):1553-1555. doi:10.1007/s00259-023-06177-5

References

6. Zhu CW, Sano M. Front Psychiatry. 2021;12:610334. doi:10.3389/fpsyt.2021.610334
7. Nianogo RA et al. JAMA Neurol. 2022;79(6):584-591. doi:10.1001/jamaneurol.2022.0976
8. Logue MW et al. Alzheimers Dement. 2022 Dec 22. Online ahead of print. doi:10.1002/alz.12870
9. Kempuraj D et al. Clin Ther. 2020;42(6):974-982. doi:10.1016/j.clinthera.2020.02.018
10. Martinez S et al. JAMA Neurol. 2021;78(4):473-477. doi:10.1001/jamaneurol.2020.5011
11. Verger A et al. Eur J Nucl Med Mol Imaging. 2023;50(6):1553-1555. doi:10.1007/s00259-023-06177-5

Publications
Publications
Topics
Article Type
Display Headline
Data Trends 2023: Alzheimer’s and Dementia
Display Headline
Data Trends 2023: Alzheimer’s and Dementia
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Eyebrow Default
Slideshow
Gate On Date
Tue, 09/19/2023 - 15:30
Un-Gate On Date
Tue, 09/19/2023 - 15:30
Use ProPublica
CFC Schedule Remove Status
Tue, 09/19/2023 - 15:30
Hide sidebar & use full width
render the right sidebar.
Conference Recap Checkbox
Not Conference Recap
Clinical Edge
Display the Slideshow in this Article
Article Slideshow Optional Introduction

Slideshow below.

Alzheimer’s disease and dementia are diseases of note in veterans, with a 10.1% prevalence at the VA.6 Military experience can be associated with other conditions, such as TBI and PTSD, which contribute to an increased risk of dementia.6,7 Certain genes are also related to elevated risk, and stress can affect dementia development.8,9 Environmental exposures, such as Agent Orange, may also increase risk in veterans.10 Despite these environmental and genetic factors, there is a silver lining: new drugs targeting amyloid beta (Aβ) plaques have shown promising results in early-stage Alzheimer’s disease.11

Slide
Medscape Article
Display survey writer
Reuters content
Disable Inline Native ads
WebMD Article
Slide Media